SEBI Reg. Investment Advisor

Download App
Help Center Pricing
Money Works 4 Me Logo MoneyWorks4Me
Login Get Free Account
Sign Up

MoneyWorks4Me

Log In Sign Up Schedule Free 15‑min Call
Login Get Free Account
Sign Up

INVESTMENT INSIGHTS

Check Before You Invest : Amrutanjan Health Care Ltd

BSE: 590006 NSE: AMRUTANJAN ISIN: INE098F01031
  |   Sector:  Healthcare   |   Industry:  Pharmaceuticals & Drugs

Snapshot

Q.1 Which industry/sub-sector does Amrutanjan Health Care Ltd belong to?
Amrutanjan Health Care Ltd belongs to the Healthcare sector, operating specifically within the Pharmaceuticals & Drugs segment.
Q.2 Is Amrutanjan Health Care Ltd a good quality company?
Amrutanjan Health Care Ltd is a good quality company, based on a consistently good 10 year financial track record.
Q.3 Is Amrutanjan Health Care Ltd undervalued or overvalued?
Amrutanjan Health Care Ltd appears Undervalued, as its key valuation ratios are below with their past averages.
Q.4 Is Amrutanjan Health Care Ltd a good buy now?
Amrutanjan Health Care Ltd is a neutral opportunity now, based on stable price trend analysis suggesting prices may move sideways. However, you need to check its quality and valuation before making a decision

Performance Analysis

Q.1 Revenue growth of Amrutanjan Health Care Ltd?
Amrutanjan Health Care Ltd revenue growth is 7.3% for FY-2025 , which is below its 5 year CAGR of 11.6% , indicating slower growth.
Q.2 Gross Profit margin of Amrutanjan Health Care Ltd?
Amrutanjan Health Care Ltd Gross profit margin which is the profit after deduction of direct costs, is 16.8% for FY-2025 , which is in line with its 5 year median of 16.8% , indicating stable margins.
Q.3 Operating Profit Margin of Amrutanjan Health Care Ltd?
Amrutanjan Health Care Ltd Operating Profit Margin which is the profit after deduction of all operating costs, is 12.91% for FY-2025 , which is in line with its 5 year median of 12.91% indicating stable margins.
Q.4 Net Profit Margin of Amrutanjan Health Care Ltd?
Amrutanjan Health Care Ltd Net Profit Margin is 11.25% for FY-2025 , is in line with with its 5 year median of 11.25%, indicating stable margins.
Current Level Historic Median
Gross Profit Margin 16.8 16.8
Operating Profit Margin 12.91 12.91
Net Profit Margin 11.25 11.25
Q.5 Return on Asset of Amrutanjan Health Care Ltd?
Amrutanjan Health Care Ltd Return on Asset is 13%, which is in line with its 5 year historical median of 13%, indicating stable asset utilization efficiency.
Q.6 Return on Equity (ROE) of Amrutanjan Health Care Ltd?
Amrutanjan Health Care Ltd Return on equity is 16.53% for FY-2025 , which is in line with its historical median of 16.53%, indicating the business is making similar use of its shareholders capital.
Q.7 Return on capital employed (ROCE) of Amrutanjan Health Care Ltd?
Amrutanjan Health Care Ltd Return on capital employed is 22.58% for FY-2025 , which is above its estimated weighted average cost of capital(WACC) 14%, indicating value creation.
Q.8 Cash conversion cycle of Amrutanjan Health Care Ltd?
Amrutanjan Health Care Ltd Cash conversion cycle is 5 days, above its historical median of 0 days, indicating deteriorated working capital management. However, you need to compare this with its peers in the industry.
Current Level Historic Median
Asset Turnover 1.16 1.17
ROE 16.53 16.53
ROCE 22.58 22.58
Cash Conversion Cycle 5 days -
Q.9 Debt to Equity ratio of Amrutanjan Health Care Ltd?
Amrutanjan Health Care Ltd Debt-to-Equity ratio is 0.00 , which is lower with the industry average of 0.15 , indicating lower debt levels in the industry.
Q.10 Debt to cash flow from operations of Amrutanjan Health Care Ltd?
Amrutanjan Health Care Ltd Debt to cash flow from operations is 0 , which is at a healthy level.

Ownership & governance

Q.1 Promoter shareholding and pledge status of Amrutanjan Health Care Ltd?
Promoters hold 46.52% of the Amrutanjan Health Care Ltd, with 0.00% of their stake pledged, indicating no pledge risk.

Peer comparison (industry-wise, mcap)

Q.1 Revenue growth of Amrutanjan Health Care Ltd vs industry peers?
Amrutanjan Health Care Ltd revenue CAGR is 11.56% , compared to the industry median CAGR of 5.54% , indicating faster growth and gaining its market share.
Profit Metrics
Current Level Industry Median
Revenue 451.8 137.1
Gross Profit 75.9 15.1
Operating Profit 58 16
Net Profit 51 5.6
Operating Efficiency
Current Level Industry Median
Asset Turnover 1.16 0.8
ROE 16.53 8.91
ROCE 22.58 11.59
Cash Conversion Cycle (days) 4.92 76

Valuation & price assessment

Q.1 Stock return of Amrutanjan Health Care Ltd over the last decade?
Over the last 9 year(s), the stock has delivered a CAGR of 9.5% based on the current price.
Q.2 What return has the stock given over the last decade?
9Y 5Y 3Y 1Y
Share Price 9.5% -2.2% -2.7% -19%
Q.3 Valuation ratios of Amrutanjan Health Care Ltd vs historical?
The current P/E is lower that its historical median.
Q.4 How do the current valuation ratios measure up against the historic numbers and the current industry numbers?
Valuation Ratios Current Historic Median Industry Median
Price to Earnings 27.37 42.90 40.28
Price to Book 4.31 8.34 2.77
Price to Sales 3.19 5.25 2.65
EV to EBITDA 17.47 27.64 15.67

Check more companies

1. Ajanta Pharma
2. JB Chem & Pharma
3. Emcure Pharma
4. Gland Pharma
5. Wockhardt
6. Pfizer
7. Astrazeneca Pharma I
8. Sai Life Sciences
9. Natco Pharma
10. Eris Lifesciences
2026 ©The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me® is a registered trademark of The Alchemists Ark Pvt. Ltd.

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×